Evidence map›Paper›PMID 31692473›Full record

ArticleActa crystallographica. Section D, Structural biology2019

The evolving story of AtzT, a periplasmic binding protein.

Matthew L Dennis, Lygie Esquirol, Tom Nebl, Janet Newman, Colin Scott, Thomas S Peat

Open access · hybridAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matthew L DennisBiomedical Manufacturing Program, CSIRO, 343 Royal Parade, Parkville, VIC 3052, Australia.ORCID 0000-0001-9598-8469
Lygie EsquirolCSIRO Synthetic Biology Future Science Platform, GPO Box 1700, Acton, Canberra, ACT 2601, Australia.
Tom NeblBiomedical Manufacturing Program, CSIRO, 343 Royal Parade, Parkville, VIC 3052, Australia.
Janet NewmanBiomedical Manufacturing Program, CSIRO, 343 Royal Parade, Parkville, VIC 3052, Australia.ORCID 0000-0003-2666-3219
Colin ScottCSIRO Synthetic Biology Future Science Platform, GPO Box 1700, Acton, Canberra, ACT 2601, Australia.
Thomas S PeatBiomedical Manufacturing Program, CSIRO, 343 Royal Parade, Parkville, VIC 3052, Australia.ORCID 0000-0002-6488-0831
Commonwealth Scientific and Industrial Research Organisation · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrazine is an s-triazine-based herbicide that is used in many countries around the world in many millions of tons per year. A small number of organisms, such as Pseudomonas sp. strain ADP, have evolved to use this modified s-triazine as a food source, and the various genes required to metabolize atrazine can be found on a single plasmid. The atomic structures of seven of the eight proteins involved in the breakdown of atrazine by Pseudomonas sp. strain ADP have been determined by X-ray crystallography, but the structures of the proteins required by the cell to import atrazine for use as an energy source are still lacking. The structure of AtzT, a periplasmic binding protein that may be involved in the transport of a derivative of atrazine, 2-hydroxyatrazine, into the cell for mineralization, has now been determined. The structure was determined by SAD phasing using an ethylmercury phosphate derivative that diffracted X-rays to beyond 1.9 Å resolution. `Native' (guanine-bound) and 2-hydroxyatrazine-bound structures were also determined to high resolution (1.67 and 1.65 Å, respectively), showing that 2-hydroxyatrazine binds in a similar way to the purportedly native ligand. Structural similarities led to the belief that it may be possible to evolve AtzT from a purine-binding protein to a protein that can bind and detect atrazine in the environment.

Indexed as

ATP-Binding Cassette TransportersAtrazineCrystallography, X-RayHydrolasesPeriplasmic Binding ProteinsProtein Structure, TertiaryPseudomonasATP-Binding Cassette TransportersAtrazineHydrolasesPeriplasmic Binding ProteinsatrazineAtzTperiplasmic binding proteinsSAD phasing

Identifiers

PMID31692473
PMCPMC6834077
OpenAlexW2984295779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.